Dow Down 1.40% Nasdaq Down 1.59%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
9.80 Oct 1, 4:00PM EDT
|Pre-Market : 10.08 Up 0.28 (2.86%) 9:11AM EDT - Nasdaq Real Time Price
Prev Close:9.80
Open:N/A
Bid:10.05 x 2000
Ask:10.10 x 12500
1y Target Est:21.00
Beta:3.39
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:6.52 - 15.80
Volume:1,300
Avg Vol (3m):1,355,580
Market Cap:591.90M
P/E (ttm):N/A
EPS (ttm):-1.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
INO 0.00%591.90M
AZN89.08B
PFE184.84B
SNY146.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):34.05
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.70
Quarterly EPS Est (Sep-14) :-0.14
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., together with its subsidiaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback